Utilization and outcomes of adjuvant therapy for stage II and III uterine leiomyosarcoma

Diggs, A., Sia, T. Y., Huang, Y., Gockley, A., Melamed, A., Khoury-Collado, F., St. Clair, C., Hou, J. Y., Hershman, D. L., & Wright, J. D. (2022). Utilization and outcomes of adjuvant therapy for stage II and III uterine leiomyosarcoma. Gynecologic Oncology, 166(2), 308–316. https://doi.org/10.1016/j.ygyno.2022.05.018
Authors:
Alexandra Diggs
Tiffany Y. Sia
Yongmei Huang
Allison Gockley
Alexander Melamed
Fady Khoury-Collado
Caryn St. Clair
June Y. Hou
Dawn L. Hershman
Jason D. Wright
Affiliated Authors:
Alexandra Diggs
Yongmei Huang
Allison Gockley
Alexander Melamed
Fady Khoury-Collado
Caryn St. Clair
June Y. Hou
Dawn L. Hershman
Jason D. Wright
Columbia Affiliation:
Subjects:
Chemotherapy, Adjuvant (MeSH)
Leiomyosarcoma (MeSH)
Pelvic Neoplasms (MeSH)
Uterine Neoplasms (MeSH)
Author Keywords:
chemotherapy
leiomyosarcoma
radiation therapy
elink
Publication Type:
Article
Unique ID:
10.1016/j.ygyno.2022.05.018
PMID:
35660331
DOI:
10.1016/j.ygyno.2022.05.018
Journal:
Gynecologic Oncology
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View PubMed Record

Record Created: